Sun Pharmaceuticals reported INR859M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Aspen Pharmacare ZAR 631.5M 301.5M Jun/2024
Bharat Petroleum INR 6.27B 305.5M Jun/2026
Cipla INR 170.3M 39M Jun/2026
Dr.Reddys Laboratories INR 1.26B 198M Jun/2026
Jiangsu Hengrui CNY 254.59M 253.85M Sep/2025
Sh Fosun Pharma CNY 321.25M 2M Sep/2025
Sun Pharmaceuticals INR 859M 139.6M Mar/2026
UPL INR 8.36B 620M Mar/2026